Stay updated on Milademetan Safety in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check16 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedAdded Revision: v3.4.2 to the page; Removed the older funding notice (v3.4.1). These changes do not modify the study content, eligibility, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check52 days agoChange DetectedA site-wide notice about a lapse in government funding and an update from version v3.4.0 to v3.4.1 was added to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedThe page adds a 'Show glossary' option and makes minor label/capitalization updates, along with a revision indicator (v3.4.0) replacing the prior version (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check73 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.